| 04/01/22 | 12:28:56 | 4 Jan 2022 | | Total Voting Rights |
| 23/12/21 | 13:11:05 | 23 Dec 2021 | | Director/PDMR Shareholding |
| 22/12/21 | 14:57:00 | 22 Dec 2021 | | Director/PDMR Shareholding |
| 21/12/21 | 07:00:02 | 21 Dec 2021 | | ViiV Healthcare announces FDA approval of Apretude |
| 20/12/21 | 07:00:07 | 20 Dec 2021 | | Consumer Healthcare Chair Designate appointed |
| 17/12/21 | 12:48:46 | 17 Dec 2021 | | Xevudy approved in Europe to treat COVID-19 |
| 15/12/21 | 07:00:02 | 15 Dec 2021 | | GSK/Sanofi COVID-19 vaccine booster & Ph3 update |
| 13/12/21 | 11:25:08 | 13 Dec 2021 | | Director/PDMR Shareholding |
| 09/12/21 | 16:35:46 | 9 Dec 2021 | | Director/PDMR Shareholding |
| 07/12/21 | 12:00:09 | 7 Dec 2021 | | Medicago/GSK COVID-19 vaccine positive Ph3 data |
| 07/12/21 | 07:07:28 | 7 Dec 2021 | | Sotrovimab retains its activity vs Omicron variant |
| 02/12/21 | 07:02:05 | 2 Dec 2021 | | Sotrovimab retains its activity vs Omicron variant |
| 24/11/21 | 16:17:43 | 24 Nov 2021 | | Director/PDMR Shareholding |
| 24/11/21 | 16:00:09 | 24 Nov 2021 | | GSK publishes provisional 2022 dividend dates |
| 23/11/21 | 15:06:44 | 23 Nov 2021 | | Director/PDMR Shareholding |
| 17/11/21 | 07:00:06 | 17 Nov 2021 | | Nucala approved in Europe for more indications |
| 15/11/21 | 16:37:51 | 15 Nov 2021 | | Block listing Interim Review |
| 12/11/21 | 12:00:03 | 12 Nov 2021 | | Phase III IM administration data for sotrovimab |
| 12/11/21 | 09:23:55 | 12 Nov 2021 | | Director/PDMR Shareholding |
| 10/11/21 | 11:28:50 | 10 Nov 2021 | | Director/PDMR Shareholding |
| 05/11/21 | 17:33:01 | 5 Nov 2021 | | GSK shares positive Phase III data for daprodustat |
| 01/11/21 | 17:11:05 | 1 Nov 2021 | | Total Voting Rights |
| 27/10/21 | 14:23:48 | 27 Oct 2021 | | Director/PDMR Shareholding |
| 27/10/21 | 12:00:00 | 27 Oct 2021 | | 3rd Quarter Results |
| 27/10/21 | 09:00:01 | 27 Oct 2021 | | Directorate Change |
| 15/10/21 | 14:41:05 | 15 Oct 2021 | | Director/PDMR Shareholding |
| 14/10/21 | 16:31:08 | 14 Oct 2021 | | Director/PDMR Shareholding |
| 14/10/21 | 16:28:15 | 14 Oct 2021 | | Director/PDMR Shareholding |
| 13/10/21 | 13:55:23 | 13 Oct 2021 | | Director/PDMR Shareholding |
| 12/10/21 | 15:17:56 | 12 Oct 2021 | | Director/PDMR Shareholding |
| 12/10/21 | 13:36:19 | 12 Oct 2021 | | Director/PDMR Shareholding |
| 12/10/21 | 13:33:36 | 12 Oct 2021 | | Director/PDMR Shareholding |
| 12/10/21 | 13:30:42 | 12 Oct 2021 | | Director/PDMR Shareholding |
| 12/10/21 | 13:28:02 | 12 Oct 2021 | | Director/PDMR Shareholding |
| 01/10/21 | 11:54:37 | 1 Oct 2021 | | Total Voting Rights |
| 24/09/21 | 17:28:28 | 24 Sept 2021 | | Director/PDMR Shareholding |
| 22/09/21 | 15:58:02 | 22 Sept 2021 | | Director/PDMR Shareholding |
| 20/09/21 | 14:42:16 | 20 Sept 2021 | | Director Declaration |
| 13/09/21 | 17:26:22 | 13 Sept 2021 | | Director/PDMR Shareholding |
| 09/09/21 | 16:42:22 | 9 Sept 2021 | | Director/PDMR Shareholding |
| 07/09/21 | 16:54:06 | 7 Sept 2021 | | Director/PDMR Shareholding |
| 03/09/21 | 09:32:19 | 3 Sept 2021 | | Director/PDMR Shareholding |
| 01/09/21 | 11:44:39 | 1 Sept 2021 | | Total Voting Rights |
| 31/08/21 | 07:00:11 | 31 Aug 2021 | | SK bio & GSK start Ph3 Covid-19 vaccine trial |
| 25/08/21 | 14:01:31 | 25 Aug 2021 | | Director/PDMR Shareholding |
| 23/08/21 | 16:39:56 | 23 Aug 2021 | | Director/PDMR Shareholding |
